EnteroMedics Announces First vBloc(R) Neurometabolic Therapy Implant at McGuire Veterans Affairs Medical Center

ST. PAUL, Minn., May 18, 2017 -- (Healthcare Sales & Marketing Network) -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today a... Devices, Neurology EnteroMedics, vBloc , Neurometabolic Therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news